The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A Randomized Controlled Trial of D-Cycloserine Enhancement of Exposure Therapy for Social Anxiety Disorder
Abstract
Background Pilot research has suggested that D-cycloserine (DCS) enhances treatment outcomes for anxiety disorders when employed as an adjunct to exposure therapy (ET). The aim of this study was to determine whether 50 mg of DCS enhances ET for social anxiety disorder (SAD) according to a comprehensive set of symptom and life impairment measures.Methods In a randomized double-blind placebo-controlled trial, we administered 50 mg of DCS or placebo in combination with ET to 56 participants who met primary diagnosis for SAD.Results Participants administered DCS reported greater improvement on measures of symptom severity, dysfunctional cognitions, and life-impairment from SAD in comparison with placebo-treated participants. Effect sizes were mostly in the medium range. Results also indicated that the amount of adaptive learning about one's ability to give speeches in front of an audience interacted with DCS to enhance treatment outcome.Conclusions This study shows that the administration of DCS before ET enhances treatment outcomes for SAD. Results also provide the first preliminary evidence to suggest that DCS moderates the relationship between a reduction in negative appraisals about one's speech performance and improvement in overall SAD symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For SAD, early studies on D-cycloserine administration during exposure in vivo have yielded promising results (Guastella et al., 2008; Hofmann et al., 2006; Rodrigues et al., 2014)”
From Virtual Reality exposure therapy in the treatment of public speaking anxiety and social anxiety disorder (2024) · cites this paper as Guastella et al., 2008
In the citing paper
“Recently, DCS combined with imaginal or virtual reality exposure (VRE) therapy has been shown to reduce length of treatment for some anxiety disorders, including acrophobia (Ressler et al, 2004), social phobia (Guastella et al, 2008; Hofmann et al, 2006), and panic disorder (Otto et al, 2010), which, like PTSD, include learned avoidance and cued emotional distress as salient symptoms.”
From D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial (2014) · cites this paper as Guastella et al, 2008
In the citing paper
“In humans, DCS administration can likewise facilitate the loss of fear resulting from exposure that causes incomplete fear loss in controls (acrophobia: Ressler, Rothbaum, Tannenbaum, Anderson, Graap, Zimand, Hodges, & Davis, 2004; social phobia: Guastella, Richardson, Lovibond, Rapee, Gaston, Mitchell, & Dadds, 2008; Hofmann, Meuret, Smits, Simon, Pollack, Eisenmenger, Shiekh, & Otto, 2006;”
From D-cycloserine facilitates context-specific fear extinction learning (2008) · cites this paper as Guastella, Richardson, Lovibond, Rapee, Gaston, Mitchell, & Dadds, 2008
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Multiple regression: testing and interpreting interactions
(1992) · Choice Reviews Online · doi:10.5860/choice.29-3352 · Cited by 36,647
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Cohen, P., Cohen, P., West, S. G., & Aiken, L. S. (2014) · Psychology Press eBooks · doi:10.4324/9781410606266 · Cited by 20,870
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Kemp, F. (2003) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.1046/j.1467-9884.2003.t01-2-00383_4.x · Cited by 9,294
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
A brief version of the Fear of Negative Evaluation Scale
Leary, M. R. (1983) · Personality and Social Psychology Bulletin · doi:10.1177/0146167283093007 · Cited by 2,178
Cited by
Sorted by citations
Items 201–300 of 325
Johnson, S. B., & Anderson, P. L. (2016) · Anxiety Stress & Coping · doi:10.1080/10615806.2016.1138289 · Cited by 14
Rapee, R. M., Jones, M. P., Hudson, J. L., Malhi, G. S., Lyneham, H. J., & Schneider, S. C. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.10.004 · Cited by 14
Self-citationd-Cycloserine and estradiol enhance fear extinction in nulliparous but not primiparous female rats
Tang, S., & Graham, B. M. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107088 · Cited by 16
The Future and Promise of Cognitive Behavioral Therapy: A Commentary
Zinbarg, R. E., Mashal, N. M., Black, D. A., & Flückiger, C. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.003 · Cited by 11
Modern concepts of pathogenetic therapy of anxiety disorders
Grigorova, O., Ахапкин, Р. В., & Aleksandrovsky, Y. A. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119101111 · Cited by 10
Toxina botulínica como tratamento para fobia social generalizada com hiperidrose
Lessa, L. D. R., & Fontenelle, L. F. (2011) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832011000200008 · Cited by 10
Stylianakis, A. A., Richardson, R., & Baker, K. (2019) · Behavioral Neuroscience · doi:10.1037/bne0000326 · Cited by 11
Self-citationSimple and efficient synthetic routes to d-cycloserine
Kim, H., & Park, K. J. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.01.089 · Cited by 11
Slattery, D. A., Neumann, I. D., Flor, P. J., & Zoicas, I. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.010 · Cited by 10
Effects of d -cycloserine on individual differences in relapse of fear
King, G., Graham, B. M., & Richardson, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.005 · Cited by 9
Self-citationCombining d-cycloserine and exposure-based CBT for the anxiety disorders.
Deveney, C. M., McHugh, R. K., Tolin, D. F., Pollack, M. H., & Otto, M. W. (2009) · Cited by 9
Efectos del estrés sobre los procesos de plasticidad y neurogénesis: una revisión
Zárate, S., Acevedo-Triana, C. A., Sarmiento-Bolaños, M. J., Cárdenas, F. P., & León, L. A. (2014) · Universitas Psychologica · doi:10.11144/javeriana.upsy13-3.eepp · Cited by 12
Woud, M. L., Blackwell, S. E., Steudte‐Schmiedgen, S., Browning, M. D., Holmes, E. A., Harmer, C. J., Margraf, J., & Reinecke, A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754679 · Cited by 8
Rodgers, R. J., Howard, K., Stewart, S., Waring, P., & Wright, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.005 · Cited by 8
d-Cycloserine-Augmented Behavior Therapy for Body Dysmorphic Disorder: A Preliminary Efficacy Trial
Weingarden, H. M., Mothi, S. S., Ladis, I., Hoeppner, S. S., Reese, H. E., Timpano, K. R., Siev, J., Rasmussen, J. L., Ragan, J. D., Dougherty, D. D., et al. (2019) · Cognitive Therapy and Research · doi:10.1007/s10608-019-10015-0 · Cited by 7
Gomes, F. V., Kakihata, A. M., Semedo, A. C. G., Hott, S. C., Uliana, D. L., Guimarães, F. S., & Resstel, L. B. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.009 · Cited by 8
Leslie, J. C., & Norwood, K. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.02.002 · Cited by 9
Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders
Choi, K., & Kim, Y. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.003 · Cited by 8
Aggarwal, R., Kunik, M. E., & Asghar‐Ali, A. A. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160045 · Cited by 9
Domschke, K., Kapfhammer, H., & Deckert, J. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_69 · Cited by 9
Novel practical synthesis of d-cycloserine
Kim, H., & Park, K. J. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.05.120 · Cited by 8
Chapter 50. Treatment of Anxiety Disorders
Choi, S., & Stein, M. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as50 · Cited by 7
A precision medicine approach to pharmacological adjuncts to extinction: A call to broaden research
King, G., Baker, K. D., Bisby, M. A., Chan, D., Cowan, C. S. M., Stylianakis, A. A., Zimmermann, K. S., & Richardson, R. (2019) · Psychopharmacology · doi:10.1007/s00213-018-4999-0 · Cited by 6
Self-citationMolecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq
Malan‐Müller, S., Fairbairn, L., Daniels, W. M. U., Dashti, M. J. S., Oakeley, E. J., Altorfer, M., Kidd, M., Seedat, S., Gamieldien, J., & Hemmings, S. M. J. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9727-4 · Cited by 5
A New Appraisal of Combined Treatments for PTSD in the Era of Psychotherapy Adjunctive Medications
Sheerin, C. M., Seim, R. W., & Spates, C. R. (2011) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-011-9195-z · Cited by 6
Byrne, S., Farrell, L. J., Storch, E. A., & Rapee, R. M. (2014) · Psychopathology Review · doi:10.5127/pr.033013 · Cited by 6
Self-citationNeurobiologische Grundlagen von psychotherapeutischen Interventionen
Bohus, M., Mauchnik, J., & Schmahl, C. G. (2009) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.57.2.97 · Cited by 6
Malan‐Müller, S., Fairbairn, L., Hart, S. A., Daniels, W. M. U., Dashti, M. J. S., Kidd, M., Seedat, S., Gamieldien, J., & Hemmings, S. M. J. (2017) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000176 · Cited by 6
Treatments for childhood anxiety disorders: integrating physiological and psychosocial interventions
Rapee, R. M. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.85 · Cited by 6
Self-citationFinnegan, S., Harrison, O. K., Booth, S., Dennis, A., Ezra, M., Harmer, C. J., Herigstad, M., Guillaume, B., Nichols, T. E., Rahman, N. M., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00479-2022 · Cited by 5
Enhancing Exposure Therapy for PTSD Using d-Cycloserine
Burton, M. S., Youngner, C., McCarthy, A. J., Rothbaum, A. O., & ROTHBAUM, B. O. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7522-5_18 · Cited by 5
Kappelmann, N., Suesse, M., Steudte‐Schmiedgen, S., Kaldewaij, R., Browning, M. D., Michael, T., Rinck, M., & Reinecke, A. (2019) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2019.101546 · Cited by 5
Pharmacological Treatment of Social Anxiety Disorder
Masdrakis, V. G., Turic, D., & Baldwin, D. S. (2013) · Modern trends in psychiatry · doi:10.1159/000351960 · Cited by 5
Social Anxiety Disorder: Assessment and Treatment
Ginzburg, D. M., Schreiber, F., & Stangier, U. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch47 · Cited by 6
Ledley, D. R., Erwin, B. A., Morrison, A. S., & Heimberg, R. G. (2017) · Psychopathology · doi:10.1002/9781394258949.ch2 · Cited by 5
Mechanisms of Action in the Treatment of Social Anxiety Disorder
Otto, M. W., Safren, S. A., & Hearon, B. A. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00027-3 · Cited by 5
Cognitive Enhancers in Exposure Therapy for Anxiety and Related Disorders
Hofmann, S. G., Gutner, C. A., & Asnaani, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3342-2_6 · Cited by 3
Hou, Y., & Lai, C. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12030075 · Cited by 4
Extinktion: Neurowissenschaftliche Erkenntnisse zur Frage, wie Menschen sich ändern
Hamm, A. O., Wendt, J., & Volkmann, M. (2017) · Verhaltenstherapie · doi:10.1159/000455659 · Cited by 6
Treatment Resistant OCD: Conceptualization and Treatment
Neziroglu, F. A., & Mancusi, L. M. (2014) · Current Psychiatry Reviews · doi:10.2174/1573400510666140620001140 · Cited by 6
Sewart, A. R., McGlade, A. L., Treanor, M., Fanselow, M. S., & Craske, M. G. (2021) · Biological Psychology · doi:10.1016/j.biopsycho.2021.108167 · Cited by 4
Christmas, D. M., Diaper, A., Wilson, S. J., Rich, A. S., Phillips, S. M., de Haes, J. U., Sjögren, M. J. C., & Nutt, D. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2384 · Cited by 4
Psychotropic Treatment of Autism
Pallanti, S., Bencini, L., Cantisani, A., & Hollander, E. (2015) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000363614 · Cited by 4
dos Santos, L. F., Osório, F. D. L., Loureiro, S. R., Hallak, J. E. C., & Crippa, J. A. S. (2011) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832011000600005 · Cited by 4
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Schneier, F. R., Okuda, M., & Liebowitz, M. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00019-5 · Cited by 4
Andrews, A. R., Gomez, D., Larey, A., Pacl, H., Burchette, D., Rodríguez, J. H., Pastrana, F. A., & Bridges, A. J. (2016) · Families Systems & Health · doi:10.1037/fsh0000224 · Cited by 4
The Biology and Efficacy of Combination Strategies for Anxiety Disorders
Ganasen, K. A., & Stein, D. J. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch1 · Cited by 4
Translational Research in Social Anxiety: Summary of Newest Developments and Future Directions
Fang, A., & Hofmann, S. G. (2014) · Wiley eBooks · doi:10.1002/9781118653920.ch18 · Cited by 3
Bruce, L. C., & Heimberg, R. G. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt38 · Cited by 6
A Comparison between Psychosocial and Pharmacological Treatments
Powers, M. B., Kauffman, B. Y., Diamond, A., & Smits, J. A. J. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00026-1 · Cited by 3
Social phobia: maintenance models and main components of CBT.
Marom, S., Aderka, I. M., Hermesh, H., & Gilboa‐Schechtman, E. (2009) · PubMed · Cited by 3
Learned fear and innate anxiety in rodents and their relevance to human anxiety disorders
Gordon, J. A., & Adhikari, A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.018 · Cited by 2
Comparison between Psychosocial and Pharmacological Treatments
Powers, M. B., Capozzoli, M. C., Handelsman, P. R., & Smits, J. A. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00021-3 · Cited by 3
Treatment of social anxiety disorder
Schneier, F. R., Pontoski, K. E., & Heimberg, R. G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.025 · Cited by 3
Sheerin, C. M., Kozak, A. T., Hale, A. C., Ramesh, B. K., & Spates, C. R. (2016) · Behavior Analysis Research and Practice · doi:10.1037/bar0000054 · Cited by 3
Arman, S., Soheilimehr, A., & Maracy, M. R. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.200786 · Cited by 5
Cognitive Enhancers as Adjuncts to Exposure‐based Treatments
Vervliet, B., & Vervoort, E. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch65 · Cited by 2
Pharmakotherapie bei Angsterkrankungen
Plag, J., Siegmund, A., & Ströhle, A. (2009) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.57.3.185 · Cited by 3
Sheerin, C. M. (2013) · ScholarWorks - WMU (Western Michigan University) · Cited by 3
Novel approaches in treatment of pediatric anxiety
Park, J. M., & Geller, D. A. (2014) · F1000Prime Reports · doi:10.12703/p6-30 · Cited by 2
Regorius, A., Lepper, J., Melzig, C. A., & Benke, C. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104907 · Cited by 2
Advances in Pharmacotherapy for Pediatric Anxiety Disorders
Rynn, M. A., Puliafico, A. C., Heleniak, C. M., Rikhi, P., Ghalib, K., & Vidair, H. B. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.3.foc299 · Cited by 2
Domschke, K., Kapfhammer, H., & Deckert, J. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_69-1 · Cited by 3
A case report of cognitive behavioral therapy for social anxiety
Xu, F., & Zhang, H. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1520581 · Cited by 3
Psychopharmacology of Pediatric Anxiety Disorders
Mohatt, J. W., Keller, A. E., & Walkup, J. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_14 · Cited by 2
Reaktionen auf schwere Belastungen und Anpassungsstörungen
Paulzen, M., & Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_80 · Cited by 2
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Bragdon, L., Schneier, F. R., & Liebowitz, M. R. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00022-4 · Cited by 2
Pharmacological assistance for psychotherapy
Lochtenberg, J., Kirshenbaum, A. P., & Johnson, M. W. (2021) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2021.100017 · Cited by 2
Cognitive Enhancers for the Treatment of Anxiety Disorders
Curtiss, J. E., Carpenter, J. K., Kind, S., & Hofmann, S. G. (2016) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199935291.013.15 · Cited by 2
An Evaluation of the Effects of D-Cycloserine on Operant Learning and Response Recovery
Martín, C. S., Alfaro, F., Bustamante, J., Laborda, M. A., Mallea, J., & Míguez, G. (2022) · Psykhe (Santiago) · doi:10.7764/psykhe.2021.33531 · Cited by 2
Singer, P., & Yee, B. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-53126-7_28 · Cited by 2
Elfferich, A. (2021) · Canadian Journal of Bioethics · doi:10.7202/1077629ar · Cited by 2
Pharmacologic Augmentation of Extinction Learning During Exposure Therapy for PTSD
Neylan, T. C. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14030386 · Cited by 2
Fear Not: Neurobiological Mechanisms of Fear and Anxiety
Klumpers, F. (2007) · Utrecht University Repository (Utrecht University) · Cited by 2
The Treatment of Panic Disorder and Phobias
Depreeuw, B., Andrews, L. A., Eldar, S., & Hofmann, S. G. (2017) · Wiley eBooks · doi:10.1002/9781119462996.ch4 · Cited by 3
Vorstenbosch, V., Newman, L., & Antony, M. M. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt03 · Cited by 3
Pélissolo, A. (2012) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2012.03.009 · Cited by 1
Berger, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61530-5 · Cited by 1
D-Cycloserine Augmentation of Cognitive-Behavioral Therapy for the Treatment of Anxiety Disorders
Janicak, P. G., Dattilo, N. C., Manos, R. C., Storch, E. A., & Goddard, A. W. (2011) · Psychopharm Review · doi:10.1097/01.psyphr.0000399653.06660.fa · Cited by 1
Evaluating Strategies for Combining Pharmacotherapy with Cognitive Behavioral Therapy
Charney, M. E., Calkins, A. W., Hallion, L. S., & Simon, N. M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2605-3_21 · Cited by 1
D-cycloserine en exposure in de behandeling van posttraumatische stressstoornis1
de Kleine, R. A., & van Minnen, A. (2012) · GZ - Psychologie · doi:10.1007/s41480-012-0059-2 · Cited by 1
Treatment Resistance in Anxiety Disorder: Generalized Anxiety Disorder and Social Anxiety Disorder
Lee, K. S., & Lee, S. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_14 · Cited by 1
Cognitive Behavioral Therapy for Anxiety Disorders
Wieman, S. T., Kind, S., & Baker, A. W. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-30687-8_12 · Cited by 2
Mechanisms of Action in the Treatment of Social Anxiety Disorder
Otto, M. W., Hearon, B. A., & Safren, S. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00022-5 · Cited by 1
Schmahl, C. G. (2009) · Springer eBooks · doi:10.1007/978-3-540-88489-7_4 · Cited by 1
Current and Experimental Treatments for Anxiety Disorders
Guastella, A. J., Norton, A., Alvares, G. A., & Song, Y. J. C. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0040 · Cited by 1
Self-citationTranslating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders
Ressler, K. J. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19205 · Cited by 1
Anxiety Disorders: Social Anxiety Disorder and Specific Phobia
McCabe, R. E., Hood, H. K., & Antony, M. M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch54 · Cited by 1
Malan‐Müller, S. (2014) · SUNScholar (Stellenbosch University) · Cited by 1
Helgadóttir, F. D. (2011) · Opin vísindi (Opin vísindi) · Cited by 1
Klassische Konditionierung als Erklärungsprinzip für klinisch bedeutsame Ängste
Michael, T., & Ehlers, A. (2008) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026/1616-3443.37.4.221 · Cited by 1
Exposure with acceptance-based versus habituation-based rationale for public speaking anxiety
England, E. L., Herbert, J. D., & Forman, E. M. (2010) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-3267 · Cited by 1
Finnegan, S., Harrison, O. K., Booth, S., Dennis, A., Ezra, M., Harmer, C. J., Herigstad, M., Guillaume, B., Nichols, T. E., Rahman, N. M., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4007187 · Cited by 1
Guastella, A. J., & Alvares, G. A. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch5 · Cited by 1
Self-citation(2008) · Biological Psychiatry · doi:10.1016/s0006-3223(08)00575-1 · Cited by 1
Katzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2021) · doi:10.32920/14638581.v1 · Cited by 1
Price, M. (2022) · Digital Archive @ GSU · doi:10.57709/1350605
Atypical Psychopharmacologic Strategies
Shatkin, J. P., & Janssen, A. C. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch15
Thérapies comportementales et cognitives
Pélissolo, A., & Montefiore, D. (2009) · Elsevier eBooks · doi:10.1016/b978-2-294-70563-2.00003-x
The Role of Engagement Across Conceptually Distinct Treatment Elements for Social Anxiety Disorder
Emge, T. M. (2012) · Lincoln (University of Nebraska)
Metadata
- Authors
- Guastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R.
- Affiliations
- UNSW Sydney (AU)
- Macquarie University (AU)
- Corresponding author
- Guastella, Adam J.
- ORCID
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 63
- Issue
- 6
- Pages
- 544-549
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2028445187
- Semantic Scholar
- e41984c470918166ac39c6aec20bd21dfc842860
- Cited by
- 326
- References
- 30
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 5 · 2019: 9 · 2018: 13 · 2017: 23 · 2016: 12 · 2015: 15 · 2014: 41 · 2013: 32 · 2012: 31
- FWCI
- 53.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council (350963)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- D-cycloserine, social anxiety disorder, exposure therapy, adjunctive pharmacotherapy, treatment enhancement, speech performance, dysfunctional cognitions, negative appraisals
- MeSH terms
- Adolescent, Adult, Combined Modality Therapy, Cycloserine, Desensitization, Psychologic, Double-Blind Method, Fear, Female, Humans, Male, Middle Aged, New South Wales, Phobic Disorders, Premedication, Speech
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
